RxDoctor Payments Data

Emily von Bargen, DO

Obstetrics & Gynecology · Cambridge, MANPI 1871729673

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,210 of the $11,881 with a category attached, or 60.7%. Boston Scientific accounts for 83.1% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $9,034, more than ten times the $369 reported in 2019. Among obstetrics & gynecology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,881in general payments, 2019–2025

Across 62 payments — averaging $191.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$10K
  • Axonics, Inc.$1K
  • Coloplast$566
  • Medtronic$259
  • Caldera Medical, Inc$185

What the payments were for

  • Consulting fees$7,21061%
  • Travel & lodging$1,13710%
  • Food & beverage$3,38328%
  • Education$1521%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific38$9,870
Axonics, Inc.9$1,001
Coloplast9$566
Medtronic(2 entities)5$259
Caldera Medical, Inc1$185

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,881 in reported general payments places this provider in the 95th percentile of 910 obstetrics & gynecology providers in Massachusetts.

See all obstetrics & gynecology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$217,811
Medicare patients
315
Services billed
6,390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron186$115,216
GemtesaVibegron85$81,949
Estradiol141$13,047
Mirabegron ErMirabegron20$10,156
YuvafemEstradiol60$9,722
Methenamine Hippurate114$7,500
Trospium Chloride ErTrospium Chloride14$3,531
Amitriptyline Hcl25$133
Ibuprofen41$101
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst15$85
Ciprofloxacin Hcl36$72
Oxycodone Hcl44$68
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim34$60

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Cambridge

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →